Analyst Estimates: Here's What Brokers Think Of Nomura Research Institute, Ltd. (TSE:4307) After Its Annual Report

Nomura Research Institute, Ltd. (TSE:4307) came out with its yearly results last week, and we wanted to see how the business is performing and what industry forecasters think of the company following this report. Results were roughly in line with estimates, with revenues of JP¥765b and statutory earnings per share of JP¥164. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analysts have changed their mind on Nomura Research Institute after the latest results.

We check all companies for important risks. See what we found for Nomura Research Institute in our free report.

After the latest results, the twelve analysts covering Nomura Research Institute are now predicting revenues of JP¥818.6b in 2026. If met, this would reflect a reasonable 7.0% improvement in revenue compared to the last 12 months. Per-share earnings are expected to accumulate 6.6% to JP¥175. Before this earnings report, the analysts had been forecasting revenues of JP¥820.6b and earnings per share (EPS) of JP¥175 in 2026. So it's pretty clear that, although the analysts have updated their estimates, there's been no major change in expectations for the business following the latest results.

See our latest analysis for Nomura Research Institute

The analysts reconfirmed their price target of JP¥5,233, showing that the business is executing well and in line with expectations. Fixating on a single price target can be unwise though, since the consensus target is effectively the average of analyst price targets. As a result, some investors like to look at the range of estimates to see if there are any diverging opinions on the company's valuation. There are some variant perceptions on Nomura Research Institute, with the most bullish analyst valuing it at JP¥6,000 and the most bearish at JP¥4,400 per share. This shows there is still a bit of diversity in estimates, but analysts don't appear to be totally split on the stock as though it might be a success or failure situation.

Of course, another way to look at these forecasts is to place them into context against the industry itself. The period to the end of 2026 brings more of the same, according to the analysts, with revenue forecast to display 7.0% growth on an annualised basis. That is in line with its 8.5% annual growth over the past five years. Juxtapose this against our data, which suggests that other companies (with analyst coverage) in the industry are forecast to see their revenues grow 6.2% per year. It's clear that while Nomura Research Institute's revenue growth is expected to continue on its current trajectory, it's only expected to grow in line with the industry itself.

The Bottom Line

The most important thing to take away is that there's been no major change in sentiment, with the analysts reconfirming that the business is performing in line with their previous earnings per share estimates. They also reconfirmed their revenue estimates, with the company predicted to grow at about the same rate as the wider industry. The consensus price target held steady at JP¥5,233, with the latest estimates not enough to have an impact on their price targets.

Keeping that in mind, we still think that the longer term trajectory of the business is much more important for investors to consider. At Simply Wall St, we have a full range of analyst estimates for Nomura Research Institute going out to 2028, and you can see them free on our platform here..

You can also view our analysis of Nomura Research Institute's balance sheet, and whether we think Nomura Research Institute is carrying too much debt, for free on our platform here.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.